Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fish and Richardson
Chinese Patent Office
Harvard Business School
Daiichi Sankyo
Colorcon

Generated: September 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IVABRADINE

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for Ivabradine

Trial ID Title Status Sponsor Phase Summary
NCT00143507 The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction Completed Institut de Recherches Internationales Servier Phase 3 The aim of this study is to test whether ivabradine is able to reduce cardiovascular events when given to patients with coronary artery disease and impaired heart function.
NCT00202566 Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris Completed Institut de Recherches Internationales Servier Phase 3 To test whether ivabradine when given in combination with atenolol is able to improve the exercise tolerance of patients with stable angina pectoris
NCT00202579 Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure Completed Institut de Recherches Internationales Servier Phase 2 To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Ivabradine

Condition Name

Condition Name for Ivabradine
Intervention Trials
Heart Failure 9
Coronary Artery Disease 5
Atrial Fibrillation 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ivabradine
Intervention Trials
Heart Failure 25
Coronary Artery Disease 10
Myocardial Ischemia 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ivabradine

Trials by Country

Trials by Country for Ivabradine
Location Trials
United States 17
Italy 9
China 9
United Kingdom 5
Spain 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ivabradine
Location Trials
Michigan 3
New York 2
Colorado 1
Texas 1
Ohio 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ivabradine

Clinical Trial Phase

Clinical Trial Phase for Ivabradine
Clinical Trial Phase Trials
Phase 4 26
Phase 3 14
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ivabradine
Clinical Trial Phase Trials
Completed 20
Recruiting 13
Unknown status 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ivabradine

Sponsor Name

Sponsor Name for Ivabradine
Sponsor Trials
Amgen 5
Institut de Recherches Internationales Servier 4
Servier 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ivabradine
Sponsor Trials
Other 71
Industry 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Army
Healthtrust
McKesson
Fish and Richardson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.